OPTIMIZATION-BY-DESIGN
Live / Applied — First extension granted (statement of use) (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 17 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99087625
- Mark type
- Stylized text
- Filed
- 17 Mar 2025
- Published for opposition
- 03 Feb 2026
- Attorney of record
- Ajay Jagtiani
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, biological preparations, and gene therapy products, namely, genetically engineered tissues for transplant purposes for medical or pharmaceutical purposes, namely, viral vector vaccines, and nucleic-acids delivery products for use in the treatment of genetic diseases and disorders; all the foregoing not relating to restorative components for dental implants and dental restoration systems
- Class 035 — Advertising and business services: Business collaboration services, namely, providing a national computer-based networking web site for medical researchers to collaborate across disciplines to contract for development and manufacture of gene therapy and pharmaceutical products; all the foregoing not relating to restorative components for dental implants and dental restoration systems
- Class 040 — Treatment of materials: Manufacturing services for others in the field of pharmaceuticals, biopharmaceuticals, health care products and medical products; treatment of materials, namely, pharmaceutical and chemical products and their components used in the manufacture of pharmaceuticals and biopharmaceuticals; manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; contract manufacturing of pharmaceuticals, cells and gene therapy reagents; all the foregoing not relating to restorative components for dental implants and dental restoration systems
- Class 042 — Scientific and technological services: Product development for others relating to pharmaceuticals, biopharmaceuticals; scientific and technological consulting services, namely, research and design in the field of pharmaceutical industry; product testing and research in the field of pharmaceuticals, biopharmaceuticals; industrial research in the field of pharmaceuticals, biopharmaceuticals; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; product development consultation; product research services, namely, providing analytical product testing, biosafety product testing and laboratory services for the production of pharmaceutical preparations for others; scientific and technical product development consulting for the pharmaceutical industry; research services in the field of pharmaceuticals; custom design and development of chemical reagents and biochemical assays; providing online non-downloadable computer software platform for users to access an integrated set of scientific and technical software capabilities, namely, software for enterprise resource planning, quality management, document management and sharing, learning management, laboratory information management, computerized maintenance management and data capture, built with quality and security in mind to deliver value to customers through the productization of data, adoption of advanced technologies, and focusing on collaborative total experience; all the foregoing not relating to restorative components for dental implants and dental restoration systems
Owner
- Andelyn Biosciences, Inc., Columbus, OH, US
- Andelyn Biosciences, Inc., Columbus, OH, US
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2026 — SOU EXTENSION 1 GRANTED
- 09 Sept 2026 — SOU EXTENSION 1 FILED
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
- 08 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
- 08 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
- 06 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE